Stiff government competition to attract and retain biotech has created a slew of tax credits, incentives and cash grants. Firms — from development stage to multinationals — can supplement operating capital with incentives and grants. The US federal government recently enacted refundable R&D and AMT tax credits. States such as Massachusetts have established incentive and grant programs for FDA filing fees, staff training and hiring costs, property and sales tax exemptions, refundable research credits, investment credits and extensions to the carryover periods for NOLs. Our panel will provide an overview of incentive and grant programs and how to locate and obtain them.

• Provide an extensive overview of incentive and grant programs available at various levels
• Share practical advice and insights on obtaining government funds targeted at life sciences companies
• Discuss pluses and minuses of different government funding
programs from a company perspective